Harry Liddiard’s Post

View profile for Harry Liddiard, graphic

Facilitating Partnerships within Biopharma | Crafting CGT and Biologics Manufacturing Conferences Across Europe

𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗮𝘁𝗲𝗻𝘁 𝗘𝘅𝗽𝗶𝗿𝘆 𝗪𝗮𝘃𝗲: 𝗔 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗢𝘂𝘁𝗹𝗼𝗼𝗸 𝗳𝗼𝗿 𝗣𝗵𝗮𝗿𝗺𝗮 The next five years are pivotal for pharma, with a multitude of patents set to expire. Andrew Pannu's analysis brings this into focus, charting a course from AbbVie's Humira to Merck Group's Keytruda, and more, facing the generic tide. As the 'at-risk' revenue potentially swells from $𝟰𝟭𝗕 𝘁𝗼 $𝟲𝟳𝗕, industry leaders are on the cusp of reinvention. This infographic is a clarion call to bolster R&D and innovate, ensuring the vitality of the biopharma sector. #PharmaPatents #BiopharmaStrategy

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics